CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-05 | Pieper Steven Chief Financial Officer | Grant or award | +134,333 | 158,108 | ||
| 2021-10-05 | Pieper Steven Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,843 | 16,843 | ||
| 2021-10-05 | Pieper Steven Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +2,640 | 2,640 | ||
| 2021-10-05 | Pieper Steven Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +14,036 | 14,036 | ||
| 2021-10-05 | Pieper Steven Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2021-10-05 | Pieper Steven Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +27,891 | 27,891 | ||
| 2021-10-05 | Schmid John P. Director | Grant or award | +5,659 | 5,659 | ||
| 2021-10-05 | Schmid John P. Director | Grant or award · Stock Option (Right to Buy) | +25,220 | 25,220 | ||
| 2021-10-05 | Schmid John P. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-10-05 | Schmid John P. Director | Grant or award · Stock Option (Right to Buy) | +11,228 | 11,228 | ||
| 2021-10-05 | Schmid John P. Director | Grant or award · Stock Option (Right to Buy) | +11,228 | 11,228 | ||
| 2021-10-05 | SHERMAN JEFFREY W Director | Grant or award | +50,378 | 50,378 | ||
| 2021-10-05 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +47,040 | 47,040 | ||
| 2021-10-05 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +31,360 | 31,360 | ||
| 2021-10-05 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +31,360 | 31,360 | ||
| 2021-10-05 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +19,650 | 19,650 | ||
| 2021-10-05 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-10-05 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +11,228 | 11,228 | ||
| 2021-10-05 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +11,228 | 11,228 | ||
| 2021-10-05 | JOHNSON KENNETH ERLAND See Remarks | Grant or award | +11,250 | 11,250 |
Page 17 of 18 · 354 trades